Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04599257 · ClinicalTrials.gov registry record · NA

Fat Reduction and Muscle Toning of Thighs

A NA study, sponsored by BTL Industries.

Completed
Registry status
NA
Development phase
93
Enrollment target

NCT04599257 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 93 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04599257, a NA study, has completed, sponsored by BTL Industries.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target

Study Summary

This study will evaluate the clinical efficacy and safety of a simultaneous application of high-intensity focused electromagnetic procedure and radiofrequency energy for changes in subcutaneous fat tissue and muscle toning of thighs.

Interventions

  • DEVICE BTL-899

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2020-09-15
Est. Completion 2022-01-20
Phase NA

Sponsor

BTL Industries

40 total trials

What the Registry Record Tells You About NCT04599257

The ClinicalTrials.gov registry entry for NCT04599257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which BTL-899 is the first listed.

NCT04599257 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04599257 about?

NCT04599257 is a clinical study titled "Fat Reduction and Muscle Toning of Thighs". This study will evaluate the clinical efficacy and safety of a simultaneous application of high-intensity focused electromagnetic procedure and radiofrequency energy for changes in subcutaneous fat tissue and muscle toning of thighs.

What is the current status of trial NCT04599257?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2020-09-15. Estimated completion is 2022-01-20.

What interventions are being tested in trial NCT04599257?

The interventions under investigation include: BTL-899 (DEVICE).

Who is sponsoring clinical trial NCT04599257?

This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.